A Review of Electroanalytical Techniques for Determination of Anti-HIV Drugs

Table 1

Approved anti-HIV drugs and their structure formulae.

Categories	Generic name	Structure formulae	Brand name	Manufacturer
Nucleoside reverse transcriptase inhibitors (NRTIs)	Zidovudine		Retrovir	GlaxoSmithKline
	Didanosine		Videx (tablet); Videx EC (capsule)	Bristol-Myers Squibb; Bristol-Myers Squibb
	Zalcitabine		Hivid	Hoffmann-La Roche
	Stavudine		Zerit	Bristol-Myers Squibb
	Lamivudine		Epivir	GlaxoSmithKline
	Abacavir		Ziagen	GlaxoSmithKline
	Emtricitabine		Emtriva	Gilead Sciences
Nucleotide reverse transcriptase inhibitors (NtRTIs)	Tenofovir		Viread	Gilead Sciences
Nonnucleoside reverse transcriptase inhibitors (NNRTIs)	Nevirapine		Viramune	Boehringer Ingelheim
	Delavirdine		Rescriptor	Pfizer
	Efavirenz		Sustiva; Stocrin	Bristol-Myers SquibbMerck
	Etravirine		Intelence	Tibotec Therapeutics
Protease inhibitors (PIs)	Saquinavir		Invirase (hard gel capsule); Fortovase (soft gel capsule)	Hoffmam-La Roche; Hoffmann-La Roche
	Ritonavir		Norvir	Abbott Laboratories
	Indinavir		Crixivan	Merck
	Nelfinavir		Viracept	Agouron Pharmaceuticals
	Amprenavir		Agenerase	GlaxoSmithKline
	Lopinavir (Tritonavir)		Kaletra	Abbott Laboratories
	Atazanavir		Reyetaz	Bristol-Myers Squibb
	Fosamprenavir		Lexiva; Telzir	GlaxoSmithKline; GlaxoSmithKline
	Tipranavir		Aptivus	Boehringer Ingelheim
	Darunavir		Prezista	Tibotec, Inc.
Integrase inhibitors (INIs)	Raltegravir		Isentress	Merck & Co., Inc.
Cell entry inhibitors and co-receptor inhibitors	Maraviroc		Celsentri; Selzentry	Pfizer; Pfizer
	Enfuvirtide		Fuzeon	Hoffmann-La; Roche & Trineris